Suppr超能文献

血浆中纤溶酶原激活物抑制剂存在离散结合蛋白的证据。

Evidence for a discrete binding protein of plasminogen activator inhibitor in plasma.

作者信息

Wiman B, Lindahl T, Almqvist A

机构信息

Department of Clinical Chemistry, Karolinska Hospital, Stockholm, Sweden.

出版信息

Thromb Haemost. 1988 Jun 16;59(3):392-5.

PMID:3142076
Abstract

Gel-filtration experiments of mixtures of functionally active and inactive forms of plasminogen activator inhibitor (PAI) with human plasma or bovine serum albumin have provided evidence for the existence of a discrete binding protein of PAI in plasma. Most likely it is a glycoprotein with a molecular weight of approximately 150,000. The data suggest that it forms a very stable complex with functionally active forms of PAI, but not with the inactive or "latent" PAI. However, the PAI activity seems not to be significantly altered by the interaction with the binding protein. Assuming that a stoichiometric complex is formed, titration experiments suggest that a pool of normal human plasma contains about 40-50 mg of PAI-binding protein liter.

摘要

对纤溶酶原激活物抑制剂(PAI)功能活性形式与非活性形式的混合物,分别与人血浆或牛血清白蛋白进行凝胶过滤实验,结果表明血浆中存在一种PAI离散结合蛋白。它很可能是一种分子量约为150,000的糖蛋白。数据显示,它与PAI的功能活性形式形成非常稳定的复合物,但不与非活性或“潜在”PAI形成复合物。然而,PAI活性似乎不会因与结合蛋白相互作用而发生显著改变。假设形成了化学计量复合物,滴定实验表明,正常人血浆中每升约含有40 - 50毫克PAI结合蛋白。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验